Revenue
-
Net Income
-$206.7M
▼ 49.6% YoY
EPS
$-1.34
▼ 32.7% YoY
Cash
$162.1M
▲ 227.4% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Carson William H. | Buy | Apr 10, 2026 | 8.0K | $6.20 | $50K | Form 4 ↗ |
Carson William H. | Buy | Mar 10, 2026 | 8.0K | $5.67 | $45K | Form 4 ↗ |
Dananberg Jamie CHIEF MEDICAL OFFICER | Sell | Mar 2, 2026 | 5.8K | $5.43 | $32K | Form 4 ↗ |
Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sell | Mar 2, 2026 | 4.3K | $5.42 | $24K | Form 4 ↗ |
Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sell | Mar 2, 2026 | 5.6K | $5.42 | $30K | Form 4 ↗ |
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sell | Mar 2, 2026 | 5.9K | $5.43 | $32K | Form 4 ↗ |
Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sell | Mar 2, 2026 | 5.6K | $5.42 | $30K | Form 4 ↗ |
Dananberg Jamie CHIEF MEDICAL OFFICER | Grant | Feb 19, 2026 | 56.3K | $0.00 | $0 | Form 4 ↗ |
Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant | Feb 19, 2026 | 62.5K | $0.00 | $0 | Form 4 ↗ |
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Grant | Feb 19, 2026 | 62.5K | $0.00 | $0 | Form 4 ↗ |
Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant | Feb 19, 2026 | 62.5K | $0.00 | $0 | Form 4 ↗ |